As the most respected attorney in Los Angeles, Cameron Y. Brock and his team at the Law Offices of Burg & Brock consider it their duty to stay apprised of important legal stories throughout the U.S. and the globe. Often, in our research, we like to share the stories we find with friends, clients, or simply those interested in current legal news.
With over 90 years of collective legal experience, we have become renowned for our staggeringly successful record as vehicle accident, wrongful death and personal injury lawyers. However, our legal expertise also includes product liability, which is why we have been particularly concerned about a recent case regarding the drug Liptruzet, reported by LawyersandSettlements.com. Even though the drup has only recently been introduced on the market, some critics are questioning why the drug received approval.
A combination of the drugs Lipitor and Zetia, Steven Nissen of the Cleveland Clinic says that since teh druge has not been proven to prevent heart attacks and strokes, approving it in combination with another drug doesn't make sense. Forbes says that Zetia has been shown to lower low-density lipoproteins but has not been proven in studies to prevent heart attacks or strokes.
Merck has said it is confident in its drug, however, thanks to the important work for liability attorneys, the company is still being taken to task to ensure their products are true to the company's claims. Whether you require a personal injury, product liability or even a vehicle accident lawyer, contact the Law Offices of Burg & Brock today for the best legal counsel in Los Angeles.
No comments:
Post a Comment